Compare UL & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UL | HCA |
|---|---|---|
| Founded | 1930 | 1968 |
| Country | United Kingdom | United States |
| Employees | 96092 | N/A |
| Industry | Package Goods/Cosmetics | Hospital/Nursing Management |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.1B | 105.5B |
| IPO Year | N/A | 2009 |
| Metric | UL | HCA |
|---|---|---|
| Price | $60.04 | $388.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 20 |
| Target Price | N/A | ★ $511.84 |
| AVG Volume (30 Days) | ★ 4.1M | 1.7M |
| Earning Date | 03-12-2026 | 04-24-2026 |
| Dividend Yield | ★ 4.04% | 0.72% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | N/A | ★ 7.15 |
| Revenue | N/A | ★ $75,600,000,000.00 |
| Revenue This Year | $2.53 | $5.11 |
| Revenue Next Year | $3.78 | $4.86 |
| P/E Ratio | ★ $14.29 | $54.11 |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $54.75 | $330.00 |
| 52 Week High | $74.98 | $556.52 |
| Indicator | UL | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 60.69 | 48.97 |
| Support Level | $58.52 | $390.10 |
| Resistance Level | $61.14 | $399.38 |
| Average True Range (ATR) | 0.83 | 10.58 |
| MACD | 0.30 | 4.06 |
| Stochastic Oscillator | 95.76 | 78.42 |
Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.